Barclays’ chief executive, CS Venkatakrishnan, has been diagnosed with non-Hodgkin lymphoma, the bank has announced.
Venkatakrishnan will be undergoing treatment for the next 12 to 16 weeks.
In a letter to staff, Venkatakrishnan explained that “the good news is that the matter has been detected early”, with scans and biopsies confirming it to be very localised.
Venkatakrishnan, who was described as unflappable and popular with staff when he was appointed as CEO a year ago, wrote: “The doctors have advised that my prognosis is excellent, and my condition is curable with their prescribed regimen.
“During this period, the company will run normally, and I will continue to be actively engaged in managing it. However, I will have to work from home for some periods and not be able to travel. Fortunately, I have always exercised regularly and am strong and fit as I commence this treatment.”